Another successful J.P. Morgan #JPM26 in the books. Energized by meaningful conversations and new connections, the Tarsus team is focused on delivering even greater value for patients, physicians, and shareholders in the year ahead. Check out our CEO Bobak Azamian, MD, PhD's perspective from his Endpoints News Fireside chat below.
Great conversation with Arsalan Arif at Endpoints News at #JPM26 on how eye care’s biggest unmet needs are often hiding in plain sight, and why real progress comes from category creation, not incremental change. This mindset guides how we build, prioritize and lead at Tarsus Pharmaceuticals, Inc., with a clear focus on transformative impact for patients.